SP
ACHL
Syncona Portfolio’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-11,086,909
| Closed | -$12.6M | – | 3 |
|
2024
Q4 | $12.6M | Hold |
11,086,909
| – | – | 23.86% | 2 |
|
2024
Q3 | $11.3M | Hold |
11,086,909
| – | – | 14.01% | 2 |
|
2024
Q2 | $9.04M | Hold |
11,086,909
| – | – | 10.52% | 2 |
|
2024
Q1 | $13.9M | Hold |
11,086,909
| – | – | 9.24% | 2 |
|
2023
Q4 | $9.86M | Hold |
11,086,909
| – | – | 6.25% | 2 |
|
2023
Q3 | $10.1M | Hold |
11,086,909
| – | – | 15.03% | 2 |
|
2023
Q2 | $10.5M | Hold |
11,086,909
| – | – | 15.8% | 2 |
|
2023
Q1 | $10.6M | Hold |
11,086,909
| – | – | 17.26% | 2 |
|
2022
Q4 | $9.98M | Hold |
11,086,909
| – | – | 15.84% | 3 |
|
2022
Q3 | $25.1M | Hold |
11,086,909
| – | – | 43.54% | 1 |
|
2022
Q2 | $27.9M | Hold |
11,086,909
| – | – | 39.7% | 1 |
|
2022
Q1 | $55.5M | Hold |
11,086,909
| – | – | 53.06% | 1 |
|
2021
Q4 | $55.5M | Buy |
+11,086,909
| New | +$55.5M | 53.06% | 1 |
|